Schizophrenia Pipeline Assessment, 2023 Updates | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, and Treatment Outlook | AbbVie Inc.,Acadia Pharmaceuticals Inc
As per Global Insight services’ assessment, about 20+ prominent pharma and biotech giants are working on 20+ drugs in the Schizophrenia – pipeline landscape globally. Progressive …